Italo-British vaccine tested on kids
ROME. KAZINFORM - A coronavirus vaccine being developed by Oxford University and the Italian firm IRBM will be tested on children and the elderly as well as in adults, sources said Friday, ANSA reports.
The first-phase trials, which started in April, involved 1,000 adults under the age of 55.
Now another 10,200 people in the 56-69 age bracket as well as the over 70s and children between the ages of five and 12 will be enrolled in the programme. Meanwhile Rome's infectious disease hospital, the Spallanzani, said that it was testing the use of hyperimmune plasma from COVID convalescent patients, with two other Rome hospitals, the San Camillo and the Bambino Gesù, a paediatric facility.
- Atyrau city tightens quarantine restrictions
- ANSA: Coronavirus to push Italy's GDP down to level of 2000 - Conte
- Greece focuses on tourism as it emerges from lockdown
- Pandemic taking heavy toll on job market in S. Korea
- ANSA: Dutch-Italian-German-French COVID-vaccine alliance formed
- UAE contributes 500,000 COVID-19 testing kits worth US$10 million to World Health Organisation
- Speeches of the President of the Republic of Kazakhstan
- President's Address to the Nation
- Development of the President's Message
- Foreign Mass Media about Kazakhstan
- World and Crisis